151 related articles for article (PubMed ID: 32882204)
41. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
[TBL] [Abstract][Full Text] [Related]
42. Autoimmune Cytopenias: Diagnosis & Management.
Nixon CP; Sweeney JD
R I Med J (2013); 2016 Dec; 99(12):36-40. PubMed ID: 27902998
[TBL] [Abstract][Full Text] [Related]
43. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
[TBL] [Abstract][Full Text] [Related]
44. The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases.
Michel M; Chanet V; Dechartres A; Morin AS; Piette JC; Cirasino L; Emilia G; Zaja F; Ruggeri M; Andrès E; Bierling P; Godeau B; Rodeghiero F
Blood; 2009 Oct; 114(15):3167-72. PubMed ID: 19638626
[TBL] [Abstract][Full Text] [Related]
45. Autoimmune thrombocytopenia following peripheral blood stem cell autografting.
Ashihara E; Shimazaki C; Hirata T; Okawa K; Oku N; Goto H; Inaba T; Fujita N; Nakagawa M
Bone Marrow Transplant; 1993 Sep; 12(3):297-9. PubMed ID: 7902157
[TBL] [Abstract][Full Text] [Related]
46. Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant.
Wang Y; Chen G; Qiao S; Ma X; Tang X; Sun A; Wu D
Leuk Lymphoma; 2011 Aug; 52(8):1556-66. PubMed ID: 21649545
[TBL] [Abstract][Full Text] [Related]
47. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
48. Improving the outcome of umbilical cord blood transplantation through ex vivo expansion or graft manipulation.
Horwitz ME; Frassoni F
Cytotherapy; 2015 Jun; 17(6):730-738. PubMed ID: 25778757
[TBL] [Abstract][Full Text] [Related]
49. [Idiopathic thrombocytopenic purpura: present knowledge and future expectations].
Delgado P; García-Zueco JC; Rubio-Félix D; Giralt M
Sangre (Barc); 1992 Dec; 37(6):449-56. PubMed ID: 1293796
[No Abstract] [Full Text] [Related]
50. Management of chronic autoimmune thrombocytopenic purpura (ITP) in adults.
Garvey B
Transfus Sci; 1998 Sep; 19(3):269-77. PubMed ID: 10351139
[TBL] [Abstract][Full Text] [Related]
51. The advent of monoclonal antibodies in the treatment of chronic autoimmune diseases.
Bruno V; Battaglia G; Nicoletti F
Neurol Sci; 2011 Jan; 31 Suppl 3():283-8. PubMed ID: 20644974
[TBL] [Abstract][Full Text] [Related]
52. [Results of unrelated umbilical cord blood stem cell transplantation for 65 patients in China].
Liao C; Yang X; Xu ZP; Huang YN; Wu SQ; Chen JS; Li Y; Tang XW; Wu JY
Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):220-3. PubMed ID: 16624064
[TBL] [Abstract][Full Text] [Related]
53. Hematologic complications of rheumatic disease.
Richert-Boe KE
Hematol Oncol Clin North Am; 1987 Jun; 1(2):301-20. PubMed ID: 3115957
[TBL] [Abstract][Full Text] [Related]
54. The cellular immunology associated with autoimmune thrombocytopenic purpura: an update.
Semple JW; Lazarus AH; Freedman J
Transfus Sci; 1998 Sep; 19(3):245-51. PubMed ID: 10351136
[TBL] [Abstract][Full Text] [Related]
55. Treatment modalities of autoimmune blood disorders.
Collins PW; Newland AC
Semin Hematol; 1992 Jan; 29(1):64-74. PubMed ID: 1570545
[No Abstract] [Full Text] [Related]
56. [Acute myeloid leukemia developing secondary immune thrombocytopenia after umbilical cord blood transplantation].
Matsumoto R; Ito K; Hosono N; Matsuda Y; Tai K; Sakamaki I; Aoki G; Yamazaki H; Nakao S; Yamauchi T
Rinsho Ketsueki; 2017; 58(5):433-437. PubMed ID: 28592755
[TBL] [Abstract][Full Text] [Related]
57. Rituximab in autoimmune pancytopenia: a case report and review of literature.
Reale LD; Besa EC
Ann Hematol; 2007 Dec; 86(12):913-6. PubMed ID: 17541587
[No Abstract] [Full Text] [Related]
58. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
[TBL] [Abstract][Full Text] [Related]
59. Potential role of N-Succinyl-Chitosan in immune reconstitution after umbilical cord blood transplantation in mice.
Luo H; Li J; Chen X
Biomed Pharmacother; 2011 Dec; 65(8):578-84. PubMed ID: 20378302
[TBL] [Abstract][Full Text] [Related]
60. Cellular immune mechanisms in chronic autoimmune thrombocytopenic purpura (ATP).
Semple JW; Freedman J
Autoimmunity; 1992; 13(4):311-9. PubMed ID: 1472641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
